忘掉選股的複雜性吧,ETF賺錢更省心
阿裏好還是騰訊香,拼多多潛力大還是京東更有上漲空間?
選擇太多,也是傷腦筋的事兒。
一股腦都買了?資金不大夠?
不妨試試指數ETF,賺錢更省心。
「南方兩倍做多恆生科技ETF」(07226)較2022年10月25日低點2.74港元反彈最高至7.155港元,漲幅爲161.1%。

「南方兩倍做多恆指ETF」(07200)較2022年10月31日低點2.552港元反彈最高至5.23港元,漲幅爲104.9%。

「Invesco中國科技類股ETF」(CQQQ)較2022年10月24日低點29.84美元反彈最高至47.9美元,漲幅爲60.5%。

備註:數據截至2023/1/5。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.